Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical N(G), N(G)-dimethylarginine in human essential hypertension
(Q44064651)
scientific article
scientific article
Language:
| (P31) |
(Q13442814)
|
||||||||||||||||||||||||
| (P50) |
(Q57071845)
(Q43096626)
|
||||||||||||||||||||||||
| (P304) |
590-593
|
||||||||||||||||||||||||
| (P433) |
7 Pt 1
|
||||||||||||||||||||||||
| (P478) |
15
|
||||||||||||||||||||||||
| (P577) |
Monday, July 1, 2002
|
||||||||||||||||||||||||
| (P1433) |
(Q15762840)
|
||||||||||||||||||||||||
| (P1476) |
"Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical N(G), N(G)-dimethylarginine in human essential hypertension" (language: en)
|
||||||||||||||||||||||||
| (P2093) |
Markus P Schneider
Stefan John
Michael Gekle
|
other details